FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073230079> ?p ?o ?g. }

• W2073230079 abstract "A bstract : Activation of Kupffer cells by gut‐derived endotoxin is an important factor in ethanol hepatotoxicity. Further, it was shown that ethanol modulates both the expression and activity of several intracellular signaling molecules and transcription factors in Kupffer cells and chronic ethanol treatment enhances Kupffer cell sensitivity to endotoxin. These findings suggest that inhibition of Kupffer cell activation is effective for clinical application in alcoholic hepatitis. Recently, accumulating lines of evidence suggest a possibility that glycine is useful as an immuno‐modulating amino acid. It has been shown that a diet containing glycine improved survival in endotoxin shock by preventing Kupffer cell activation. Glycine most likely prevents the LPS‐induced elevation of intracellular Ca 2+ concentration in Kupffer cells, thereby minimizing LPS receptor signaling and cytokine production. Indeed, glycine prevents alcohol‐induced liver injury in a long‐term enteral ethanol feeding rats (Tsukamoto‐French) by decreasing production of TNF‐α in the liver. Moreover, glycine is protective against apoptosis of sinusoidal endothelial cells (SECs) that is one of the initial events in the development of liver injury. On the other hand, epidemiologic data have identified chronic alcohol consumption as a significant risk factor for carcinogenesis. Interestingly, glycine inhibits growth of tumor in vivo most likely because of the inhibition of angiogenesis. It was shown that the inhibitory effect of glycine on growth and migration of endothelial cells is due to activation of a glycine‐gated Cl − channel. It is hypothesized that the opening of this anion channel hyperpolarizes the cell membrane, blocks influx of Ca 2+ through voltage‐dependent Ca 2+ channel, thereby blunting growth factor‐mediated signaling. Therefore, glycine can be used not only for treatment of alcoholic hepatitis, but also for chemoprevention and treatment of hepatocellular carcinoma in alcoholic cirrhosis. Taken together, it is concluded that glycine is a potent therapeutic immuno‐nutrient for various kinds of chronic liver diseases including alcoholic liver disease (ALD)." @default.
• W2073230079 created "2016-06-24" @default.
• W2073230079 creator A5003135996 @default.
• W2073230079 creator A5007801419 @default.
• W2073230079 creator A5024546865 @default.
• W2073230079 creator A5053599358 @default.
• W2073230079 creator A5058386183 @default.
• W2073230079 date "2005-11-01" @default.
• W2073230079 modified "2023-09-27" @default.
• W2073230079 title "Glycine as a Therapeutic Immuno-Nutrient for Alcoholic Liver Disease" @default.
• W2073230079 cites W1520948801 @default.
• W2073230079 cites W1568259808 @default.
• W2073230079 cites W1681809231 @default.
• W2073230079 cites W1964352423 @default.
• W2073230079 cites W1982859282 @default.
• W2073230079 cites W1991261786 @default.
• W2073230079 cites W1996717793 @default.
• W2073230079 cites W1996974556 @default.
• W2073230079 cites W2003485505 @default.
• W2073230079 cites W2008086832 @default.
• W2073230079 cites W2014185375 @default.
• W2073230079 cites W2017098380 @default.
• W2073230079 cites W2019683118 @default.
• W2073230079 cites W2048717483 @default.
• W2073230079 cites W2051572903 @default.
• W2073230079 cites W2067338751 @default.
• W2073230079 cites W2067656659 @default.
• W2073230079 cites W2068972164 @default.
• W2073230079 cites W2075553837 @default.
• W2073230079 cites W2078611817 @default.
• W2073230079 cites W2087051893 @default.
• W2073230079 cites W2132433704 @default.
• W2073230079 cites W2132810971 @default.
• W2073230079 cites W2138497055 @default.
• W2073230079 cites W2142952749 @default.
• W2073230079 cites W2166542918 @default.
• W2073230079 cites W2187489219 @default.
• W2073230079 cites W4252901436 @default.
• W2073230079 cites W4301813141 @default.
• W2073230079 doi "https://doi.org/10.1097/01.alc.0000189281.82523.6c" @default.
• W2073230079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16344603" @default.
• W2073230079 hasPublicationYear "2005" @default.
• W2073230079 type Work @default.
• W2073230079 sameAs 2073230079 @default.
• W2073230079 citedByCount "25" @default.
• W2073230079 countsByYear W20732300792013 @default.
• W2073230079 countsByYear W20732300792014 @default.
• W2073230079 countsByYear W20732300792015 @default.
• W2073230079 countsByYear W20732300792016 @default.
• W2073230079 countsByYear W20732300792018 @default.
• W2073230079 countsByYear W20732300792019 @default.
• W2073230079 countsByYear W20732300792023 @default.
• W2073230079 crossrefType "journal-article" @default.
• W2073230079 hasAuthorship W2073230079A5003135996 @default.
• W2073230079 hasAuthorship W2073230079A5007801419 @default.
• W2073230079 hasAuthorship W2073230079A5024546865 @default.
• W2073230079 hasAuthorship W2073230079A5053599358 @default.
• W2073230079 hasAuthorship W2073230079A5058386183 @default.
• W2073230079 hasConcept C126322002 @default.
• W2073230079 hasConcept C185592680 @default.
• W2073230079 hasConcept C203014093 @default.
• W2073230079 hasConcept C2776637226 @default.
• W2073230079 hasConcept C2777214474 @default.
• W2073230079 hasConcept C2777575235 @default.
• W2073230079 hasConcept C2777756961 @default.
• W2073230079 hasConcept C2778690821 @default.
• W2073230079 hasConcept C2778904781 @default.
• W2073230079 hasConcept C515207424 @default.
• W2073230079 hasConcept C55493867 @default.
• W2073230079 hasConcept C71924100 @default.
• W2073230079 hasConcept C79879829 @default.
• W2073230079 hasConcept C86803240 @default.
• W2073230079 hasConcept C98274493 @default.
• W2073230079 hasConceptScore W2073230079C126322002 @default.
• W2073230079 hasConceptScore W2073230079C185592680 @default.
• W2073230079 hasConceptScore W2073230079C203014093 @default.
• W2073230079 hasConceptScore W2073230079C2776637226 @default.
• W2073230079 hasConceptScore W2073230079C2777214474 @default.
• W2073230079 hasConceptScore W2073230079C2777575235 @default.
• W2073230079 hasConceptScore W2073230079C2777756961 @default.
• W2073230079 hasConceptScore W2073230079C2778690821 @default.
• W2073230079 hasConceptScore W2073230079C2778904781 @default.
• W2073230079 hasConceptScore W2073230079C515207424 @default.
• W2073230079 hasConceptScore W2073230079C55493867 @default.
• W2073230079 hasConceptScore W2073230079C71924100 @default.
• W2073230079 hasConceptScore W2073230079C79879829 @default.
• W2073230079 hasConceptScore W2073230079C86803240 @default.
• W2073230079 hasConceptScore W2073230079C98274493 @default.
• W2073230079 hasIssue "s2" @default.
• W2073230079 hasLocation W20732300791 @default.
• W2073230079 hasLocation W20732300792 @default.
• W2073230079 hasOpenAccess W2073230079 @default.
• W2073230079 hasPrimaryLocation W20732300791 @default.
• W2073230079 hasRelatedWork W148685758 @default.
• W2073230079 hasRelatedWork W1595238154 @default.
• W2073230079 hasRelatedWork W1977818758 @default.
• W2073230079 hasRelatedWork W2064132909 @default.
• W2073230079 hasRelatedWork W2097823370 @default.
• W2073230079 hasRelatedWork W2150403205 @default.
• W2073230079 hasRelatedWork W2383251826 @default.

• next